Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Thread starter International: Top News And Analysis
Start date Mar 19, 2026

International: Top News And Analysis

Guest

Mar 19, 2026

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Prefix: N/A

Forum: World News

Start date: Mar 19, 2026

Last reply date: Mar 19, 2026

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Mar 19, 2026

Replies: 0

Views: 6

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search